2021: John Q. Adams, Sr.

John Q. Adams, Sr., serves as president of J.Q. Enterprises, a holding company for his interests in real estate and ranching. During Mr. Adams’ long career in the pharmaceutical industry, he owned three companies: Baylor Laboratories, sold to Norwich Eaton Pharmaceuticals; Allerderm, Inc., sold to Virbac Inc., in France; and Adams Laboratories, a private pharmaceutical company focused on respiratory therapy, sold to Medeva Pharmaceuticals, where from 1991 to 1995, he served as President of Medeva Americas. Mr. Adams later repurchased Adams Laboratories from Medeva and served as its Chairman and Chief Executive Officer. Adams Laboratories changed its name to Adams Respiratory Therapeutics, and Mr. Adams served as Chairman of Adams Respiratory Therapeutics Inc. until October 14, 2005. He has been Vice Chairman of CereScan, Inc ., since June 2009 and its Director since March 2009. Mr. Adams has served as a Director on several other Boards throughout his career, including Respirics, Inc., Adamis Pharmaceuticals Corporation, Medeva Americas, and Cellegy Pharmaceuticals Inc.

He also retains memberships and board positions in several professional and philanthropic organizations, including the American College of Allergy and the Vanderbilt University Voice Center. In July 2007, he was elected to the Board of Trustees for Heidelberg College in Tiffin, Ohio, and in April 2009 he was inducted into the Hall of Excellence of the Ohio Foundation of Independent Colleges which each year honors three distinguished graduates from 34 Ohio colleges. He is also an Honorary Fellow of the American Academy of Otolaryngology-Head and Neck Surgery. Mr. Adams holds a degree in Biology from Heidelberg College.